Vol 9, No 4 (2020)
Review article
Published online: 2020-06-24

open access

Page views 1191
Article views/downloads 890
Get Citation

Connect on Social Media

Connect on Social Media

Cinnamon supplementation improves blood pressure in type 2 diabetic patients: A systematic review and meta-analysis of randomized controlled trials

Ronak Jalali1, Marzieh Mahmoodi2, Seyedeh Parisa Moosavian3, Gordon A Ferns4, Zahra Sohrabi5
Clin Diabetol 2020;9(4):259-266.

Abstract

Some studies have suggested that consumption of some herbal medicines may improve blood pressure. The present systematic review and meta-analysis was conducted to assess the efficacy of cinnamon supplementation on blood pressure in type 2 diabetic patients.

The systematic search was undertaking using several online databases (PubMed, Embase, Scopus and Web of Sciences) to identify randomized controlled trials (RCTs) investigating the effect of cinnamon supplementation on systolic blood pressure (SBP) or diastolic blood pressure (DBP) in type 2 diabetic patients that were published up until 10 December 2019. Potential publication bias was assessed using the Egger regression test.

Five full-text articles were included in this meta-analysis. Pooled results of the meta-analysis on 332 participants indicated a significant reduction in SBP and DBP following cinnamon administration. No publication bias was found.

The results of the present study suggested that cinnamon might be effective in improving blood pressure in type 2 diabetic patients.

Article available in PDF format

View PDF Download PDF file

References

  1. Fagard RH. Resistant hypertension. Heart. 2012; 98(3): 254–261.
  2. Guevara SR, Parra D, Rojas L. "Teaching: Individual" to increase adherence to therapeutic regimen in people with hypertension and type-2 diabetes: protocol of the controlled clinical trial ENURSIN. BMC Nursing. 2019; 18(1): 22.
  3. Xiong XJ, Wang PQ, Li SJ, et al. Garlic for hypertension: A systematic review and meta-analysis of randomized controlled trials. Phytomedicine. 2015; 22(3): 352–361.
  4. Wang HP, Yang J, Qin LQ, et al. Effect of garlic on blood pressure: a meta-analysis. J Clin Hypertens (Greenwich). 2015; 17(3): 223–231.
  5. Galasso C, Gentile A, Orefice I, et al. Microalgal derivatives as potential nutraceutical and food supplements for human health: a focus on cancer prevention and interception. Nutrients. 2019; 11(6): 1226.
  6. Gruenwald J, Freder J, Armbruester N. Cinnamon and health. Crit Rev Food Sci Nutr. 2010; 50(9): 822–834.
  7. Rao PV, Gan SH. Cinnamon: a multifaceted medicinal plant. Evid Based Complement Alternat Med. 2014: 642942.
  8. Hamidpour R, Hamidpour M, Hamidpour S, et al. Cinnamon from the selection of traditional applications to its novel effects on the inhibition of angiogenesis in cancer cells and prevention of Alzheimer's disease, and a series of functions such as antioxidant, anticholesterol, antidiabetes, antibacterial, antifungal, nematicidal, acaracidal, and repellent activities. J Tradit Complement Med. 2015; 5(2): 66–70.
  9. Akilen R, Pimlott Z, Tsiami A, et al. Effect of short-term administration of cinnamon on blood pressure in patients with prediabetes and type 2 diabetes. Nutrition. 2013; 29(10): 1192–1196.
  10. Akilen R, Tsiami A, Devendra D, et al. Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial. Diabetic Medicine. 2010; 27(10): 1159–1167.
  11. Sengsuk C, Sanguanwong S, Tangvarasittichai O, et al. Effect of cinnamon supplementation on glucose, lipids levels, glomerular filtration rate, and blood pressure of subjects with type 2 diabetes mellitus. Diabetol Int. . 2015; 7(2): 124–132.
  12. Azimi P, Ghiasvand R, Feizi A, et al. Effects of cinnamon, cardamom, saffron, and ginger consumption on markers of glycemic control, lipid profile, oxidative stress, and inflammation in type 2 diabetes patients. Rev Diabet Stud. 2014; 11(3-4): 258–266.
  13. Wainstein J, Stern N, Heller S, et al. Dietary cinnamon supplementation and changes in systolic blood pressure in subjects with type 2 diabetes. J Med Food. 2011; 14(12): 1505–1510.
  14. Moher D, Liberati A, Tetzlaff J. Altman DGJAoim. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. 2009; 151(4): 264–269.
  15. Jalali M, Mahmoodi M, Moosavian SP, et al. The effects of ginger supplementation on markers of inflammatory and oxidative stress: A systematic review and meta-analysis of clinical trials. Phytother Res. 2020 [Epub ahead of print].
  16. Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. 2011; 343: d5928.
  17. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109): 629–634.
  18. Azimi P, Ghiasvand R, Feizi A, et al. Effect of cinnamon, cardamom, saffron and ginger consumption on blood pressure and a marker of endothelial function in patients with type 2 diabetes mellitus: A randomized controlled clinical trial. Blood Press. 2016; 25(3): 133–140.
  19. Qin B, Panickar KS, Anderson RA. Cinnamon: potential role in the prevention of insulin resistance, metabolic syndrome, and type 2 diabetes. J Diabetes Sci Technol. 2010; 4(3): 685–693.
  20. Fitzpatrick DF, Hirschfield SL, Ricci T, et al. Endothelium-dependent vasorelaxation caused by various plant extracts. J Cardiovasc Pharmacol. 1995; 26(1): 90–95.
  21. Gilani A, Jabeen Q, Khan Au, et al. Gut modulatory, blood pressure lowering, diuretic and sedative activities of cardamom. Journal of Ethnopharmacology. 2008; 115(3): 463–472.
  22. Verma SK, Jain V, Katewa SS. Blood pressure lowering, fibrinolysis enhancing and antioxidant activities of cardamom (Elettaria cardamomum). Indian Journal of Biochemistry & Biophysics. 2009; 46(6): 503–506.
  23. Roussel AM, Hininger I, Benaraba R, et al. Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese. J Am Coll Nutr. 2009; 28(1): 16–21.
  24. El-Bassossy HM, Fahmy A, Badawy D. Cinnamaldehyde protects from the hypertension associated with diabetes. Food Chem Toxicol. 2011; 49(11): 3007–3012.
  25. Preuss HG, Echard B, Polansky MM, et al. Whole cinnamon and aqueous extracts ameliorate sucrose-induced blood pressure elevations in spontaneously hypertensive rats. J Am Coll Nutr. 2006; 25(2): 144–150.
  26. Cottone S, Lorito MC, Riccobene R, et al. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. J Nephrol. 2008; 21(2): 175–179.
  27. Liao BC, Hsieh CW, Liu YC, et al. Cinnamaldehyde inhibits the tumor necrosis factor-alpha-induced expression of cell adhesion molecules in endothelial cells by suppressing NF-kappaB activation: effects upon IkappaB and Nrf2. Toxicol Appl Pharmacol. 2008; 229(2): 161–171.
  28. Ranasinghe P, Jayawardena R, Pigera S, et al. Evaluation of pharmacodynamic properties and safety of Cinnamomum zeylanicum (Ceylon cinnamon) in healthy adults: a phase I clinical trial. BMC Complementary and Alternative Medicine. 2017; 17(1): 550.
  29. Nyadjeu P, Nguelefack-Mbuyo EP, Atsamo AD, et al. Acute and chronic antihypertensive effects of Cinnamomum zeylanicum stem bark methanol extract in L-NAME-induced hypertensive rats. BMC Complement Altern Med. 2013; 13: 27.
  30. Grayson P, Kim S, LaValley M, et al. Hyperuricemia and incident hypertension: A systematic review and meta-analysis. Arthritis Care & Research. 2010; 63(1): 102–110.
  31. Rao A, Pandya V, Whaley-Connell A. Obesity and insulin resistance in resistant hypertension: implications for the kidney. Adv Chronic Kidney Dis. 2015; 22(3): 211–217.
  32. Mancia G, Bousquet P, Elghozi JL, et al. The sympathetic nervous system and the metabolic syndrome. J Hypertens. 2007; 25(5): 909–920.
  33. Maadarani O, Bitar Z, Mohsen M. Adding herbal products to direct-acting oral anticoagulants can be fatal. Eur J Case Rep Intern Med. 2019; 6(8): 001190.